Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
26470 | 208 | 34.2 | 43% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2111 | 4700 | CARDIOVASCULAR REACTIVITY//HOSTILITY//TYPE A BEHAVIOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HAIR DISTRIBUTION | Author keyword | 2 | 67% | 1% | 2 |
2 | PHYS ACT SPORT RECREAT PHASREC | Address | 2 | 50% | 1% | 3 |
3 | HART | Address | 1 | 12% | 5% | 11 |
4 | MID DIGITAL HAIR | Author keyword | 1 | 100% | 1% | 2 |
5 | UNIT HYPERTENS CARDIOVASC DIS | Address | 1 | 40% | 1% | 2 |
6 | PSYCHOSOCIAL BEHAV SCI | Address | 1 | 11% | 3% | 7 |
7 | RENAL HYPERTENS UNIT | Address | 1 | 23% | 1% | 3 |
8 | STAT CONSULTAT SERV | Address | 1 | 10% | 3% | 7 |
9 | 125IODOCYANOPINDOLOL | Author keyword | 1 | 50% | 0% | 1 |
10 | ADRENAL FATIGUE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HAIR DISTRIBUTION | 2 | 67% | 1% | 2 | Search HAIR+DISTRIBUTION | Search HAIR+DISTRIBUTION |
2 | MID DIGITAL HAIR | 1 | 100% | 1% | 2 | Search MID+DIGITAL+HAIR | Search MID+DIGITAL+HAIR |
3 | 125IODOCYANOPINDOLOL | 1 | 50% | 0% | 1 | Search 125IODOCYANOPINDOLOL | Search 125IODOCYANOPINDOLOL |
4 | ADRENAL FATIGUE | 1 | 50% | 0% | 1 | Search ADRENAL+FATIGUE | Search ADRENAL+FATIGUE |
5 | ICH E5 GUIDELINES | 1 | 50% | 0% | 1 | Search ICH+E5+GUIDELINES | Search ICH+E5+GUIDELINES |
6 | MIDDLE PHALANGEAL HAIR | 1 | 50% | 0% | 1 | Search MIDDLE+PHALANGEAL+HAIR | Search MIDDLE+PHALANGEAL+HAIR |
7 | NOREPINEPHRINE METABOLITE | 1 | 50% | 0% | 1 | Search NOREPINEPHRINE+METABOLITE | Search NOREPINEPHRINE+METABOLITE |
8 | IMPROVEMENT OF PROGNOSIS | 0 | 33% | 0% | 1 | Search IMPROVEMENT+OF+PROGNOSIS | Search IMPROVEMENT+OF+PROGNOSIS |
9 | DEFENSIVE COPING | 0 | 25% | 0% | 1 | Search DEFENSIVE+COPING | Search DEFENSIVE+COPING |
10 | PERCEPTION OF HEALTH | 0 | 13% | 1% | 2 | Search PERCEPTION+OF+HEALTH | Search PERCEPTION+OF+HEALTH |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIGITAL HAIR | 1 | 100% | 1% | 2 |
2 | THUSA | 1 | 17% | 1% | 3 |
3 | STRATEGY INDICATOR | 0 | 33% | 0% | 1 |
4 | RURAL ZULUS | 0 | 25% | 0% | 1 |
5 | KUNG SAN | 0 | 20% | 0% | 1 |
6 | OBESE HYPERTENSIVE PATIENTS | 0 | 20% | 0% | 1 |
7 | BLACK AFRICANS | 0 | 17% | 0% | 1 |
8 | SUBCLINICAL VASCULAR DISEASE | 0 | 17% | 0% | 1 |
9 | CAUCASIAN VOLUNTEERS | 0 | 10% | 0% | 1 |
10 | BLACK HYPERTENSIVE PATIENTS | 0 | 100% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Perspectives on research in hypertension | 2009 | 21 | 32 | 31% |
Hypertension in developing nations in sub-Saharan Africa | 2000 | 38 | 44 | 39% |
Systematic review: Antihypertensive drug therapy in black patients | 2004 | 81 | 52 | 17% |
Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and beta-adrenergic blockers? A systematic review | 2013 | 5 | 88 | 13% |
Hypertension in black South Africans | 1999 | 7 | 48 | 42% |
ARE THERE BETA-ADRENERGIC-RECEPTOR RESPONSE DIFFERENCES BETWEEN RACIAL GROUPS | 1991 | 7 | 42 | 33% |
ETHNIC VARIATIONS IN ESSENTIAL-HYPERTENSION - ANTHROPOLOGICAL VIEWPOINTS | 1985 | 0 | 2 | 100% |
Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks | 2005 | 3 | 57 | 14% |
The management of hypertensive disease in Black patients | 1999 | 35 | 44 | 9% |
A review and assessment of potential sources of ethnic differences in drug responsiveness | 2003 | 67 | 174 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHYS ACT SPORT RECREAT PHASREC | 2 | 50% | 1.4% | 3 |
2 | HART | 1 | 12% | 5.3% | 11 |
3 | UNIT HYPERTENS CARDIOVASC DIS | 1 | 40% | 1.0% | 2 |
4 | PSYCHOSOCIAL BEHAV SCI | 1 | 11% | 3.4% | 7 |
5 | RENAL HYPERTENS UNIT | 1 | 23% | 1.4% | 3 |
6 | STAT CONSULTAT SERV | 1 | 10% | 3.4% | 7 |
7 | AFDELING KLIN EPIDEMIOL BIOSTAT | 1 | 50% | 0.5% | 1 |
8 | HUMAN NEUROTRANSMITTERS NEUROVASC HYPERTENS | 1 | 50% | 0.5% | 1 |
9 | NEUROVASC HYPERTENS KIDNEY DIS HUMAN NEUROTRA | 1 | 50% | 0.5% | 1 |
10 | NORTH WEST UNIV | 1 | 50% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000164039 | JOHN HENRYISM//BLACK AMERICAN WOMEN//SOCIAL DIMENSIONS OF HEALTH |
2 | 0.0000108400 | ICI 206 970//POTASSIUM BLOOD//EUKALEMIC |
3 | 0.0000097699 | MINICHAL//ANTIHYPERTENSIVE DRUG CLASSES//ANTIHYPERTENSIVE REGIMENS |
4 | 0.0000085676 | TRANDOLAPRIL//MULTI PHOTON CONTAMINATION//VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY |
5 | 0.0000085334 | MED HOSP PHARM YAHATANISHI KU//4 HYDROXYPROPRANOLOL//PROPRANOLOL METABOLISM |
6 | 0.0000072086 | PREHYPERTENSION//HYPERTENSION PREVALENCE//HIGH NORMAL BLOOD PRESSURE |
7 | 0.0000071854 | MED PL PHYSIOL//BAP METABOLITES//KIDNEY NEOPLASMS THERAPY |
8 | 0.0000070278 | DOXAZOSIN//AJ 2615//MONATEPIL MALEATE |
9 | 0.0000069692 | AMOSULALOL//TERTATOLOL//DILEVALOL |
10 | 0.0000067632 | PARATHYROID HYPERTENSIVE FACTOR//DIETARY POTASSIUM//2 KIDNEY ONE CLIP |